Stock NKGN NKGEN BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Charts NKGen Biotech, Inc. Nyse

Equities

NKGN

US65488A1016

Delayed Nyse
Other stock markets
 03:07:33 2024-06-26 pm EDT 		5-day change 1st Jan Change
1.315 USD +10.50% Intraday chart for NKGen Biotech, Inc. 0.00% -84.16%
Jun. 18 NKGen Biotech, Inc. announced that it has received $0.8 million in funding from AJB Capital Investments LLC, Sandia Investment Managment LP, Diametric Capital, LP CI
Jun. 12 NKGen Biotech, Inc. Presents Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy for Solid Tumors at the 6th Annual Allogeneic Cell Therapies Summit 2024 CI

Chart: Technical Analysis

Technical analysis trends

Short TermMid-TermLong Term
Trend

Bearish

Bearish

Bearish

Resistance 3.660 3.660 3.540
Spread/Res.-64.07%-64.07%-62.85%
Spread/Supp.+47.75%+47.75%+10.50%
Support 0.8900 0.8900 1.190
  1. Stock Market
  2. Equities
  3. NKGN Stock
  4. NKGN Stock
  5. Charts NKGen Biotech, Inc.